Reports for CHEPLAPHARM ARZNEIMITTEL GMBH
Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH
Totals |
||
Shortage reports |
51 |
|
| Actual shortage: | 5 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (2%) | |
| Resolved: | 45 (88%) | |
Discontinuation Reports |
7 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 4 (57%) | |
| Reversed: | 3 (43%) | |
Late reports |
4 (7%) |
|
Overdue reports |
2 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIVOTRIL | 0.5MG | TABLET | Resolved | 2017-11-07 | 2017-12-13 | 28573 |
| RIVOTRIL | 0.5MG | TABLET | Resolved | 2018-01-03 | 2018-04-21 | 34871 |
| RIVOTRIL | 0.5MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171577 |
| RYTHMODAN | 100MG | CAPSULE | Resolved | 2021-11-18 | 2022-03-09 | 149615 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-05-09 | 2022-05-25 | 160204 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Actual shortage | 2024-06-17 | 2024-07-02 | 230712 |
| XENICAL | 120MG | CAPSULE | Resolved | 2021-05-13 | 2021-08-10 | 139254 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2020-08-31 | 2022-02-11 | 123386 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2022-07-20 | 2022-08-13 | 165082 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2024-01-04 | 2024-03-01 | 214845 |
| ONE-ALPHA | 1MCG | CAPSULE | Resolved | 2020-04-04 | 2020-05-16 | 110953 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2019-05-02 | 2019-06-04 | 83015 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2017-05-12 | 2017-07-06 | 10149 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2020-01-30 | 2020-02-19 | 104798 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2021-12-13 | 2022-02-15 | 151046 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2022-05-06 | 2022-05-25 | 160170 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2022-09-12 | 2022-12-08 | 169133 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2024-02-27 | 2024-06-29 | 220741 |
| INHIBACE | 2.5MG | TABLET | Actual shortage | 2018-11-26 | 2019-02-19 | 67581 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
| XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
| LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
| XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
| ANANDRON | 50MG | TABLET | Reversed | 2024-05-16 | 2024-07-10 | 228155 |
| SUPREFACT DEPOT 2 MONTHS | 6.3MG | IMPLANT | Reversed | 2024-05-16 | 2024-06-19 | 228169 |
| SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | Reversed | 2024-05-16 | 2024-07-10 | 228166 |
Showing 1 to 7 of 7